FibroBiologics Statistics
NASDAQ: FBLGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.11-0.03 (-2.63%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.10 -0.81%
FibroBiologics by the numbers
FibroBiologics has a market capitalization of $7.7 million based on 6.96M shares outstanding. With trailing EPS of $-5.01, FibroBiologics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.5% below its 50-day average and 59.7% below its 200-day average.
Average daily trading volume is 204.44K shares, or about $226,931 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FBLG valuation vs. peer median
| Metric | FBLG | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.72M | $7.50M | +3% |
| Avg. volume | 204.44K | 171.12K | +19% |
Peer median across 8 companies: LGVN, SNGX, CURX, SKYE, TRAW, CNSP, INM, AZTR.
Valuation
- Market cap
- $7.72M
- EPS (TTM)
- $-5.01
- Shares outstanding
- 6.96M
Price and trading
- Previous close
- 1.14
- Open
- 1.12
- Day range
- 1.05 – 1.14
- 52-week range
- 0.62 – 9.98
- Beta
- —
- Volume
- 71.86K
- Average volume
- 204.44K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 30, 2026
Additional statistics
- Market Cap
- 7.72M
- Forward Pe
- -0.34
- Eps
- -5.01
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.98
- Week52 Low
- 0.62
- Avg Volume
- 204.44K
- Shares Outstanding
- 6.96M
- Ma50
- 1.31
- Ma200
- 2.75
- Earnings Date
- Oct 30, 2026
- Pct From52w High
- -88.88%
- Pct From52w Low
- 79.03%